Merit Medical Systems' (NASDAQ:MMSI) Five-year Earnings Growth Trails the 27% YoY Shareholder Returns
Merit Medical Systems' (NASDAQ:MMSI) Five-year Earnings Growth Trails the 27% YoY Shareholder Returns
When you buy a stock there is always a possibility that it could drop 100%. But on the bright side, you can make far more than 100% on a really good stock. Long term Merit Medical Systems, Inc. (NASDAQ:MMSI) shareholders would be well aware of this, since the stock is up 227% in five years. It's also good to see the share price up 19% over the last quarter.
当您购买股票时,总有可能会下跌100%。但好的一面是,您可以在真正好的股票上获得远远超过100%的回报。长期的Merit Medical Systems, Inc. (NASDAQ:MMSI)股东对此应该有所了解,因为这只股票在五年内上涨了227%。 这一季度,股价上涨了19%,也是一件好事。
Since it's been a strong week for Merit Medical Systems shareholders, let's have a look at trend of the longer term fundamentals.
由于Merit Medical Systems股东在本周表现强劲,让我们来看看其长期基本面的趋势。
In his essay The Superinvestors of Graham-and-Doddsville Warren Buffett described how share prices do not always rationally reflect the value of a business. By comparing earnings per share (EPS) and share price changes over time, we can get a feel for how investor attitudes to a company have morphed over time.
沃伦·巴菲特在他的论文《格雷厄姆-道德斯维尔的超级投资者》中描述了股票价格并不总是合理地反映企业的价值。通过比较每股收益(EPS)和股价随时间变化的变化,我们可以了解到投资者对某家公司的态度如何随时间而变化。
Over half a decade, Merit Medical Systems managed to grow its earnings per share at 23% a year. This EPS growth is reasonably close to the 27% average annual increase in the share price. Therefore one could conclude that sentiment towards the shares hasn't morphed very much. Rather, the share price has approximately tracked EPS growth.
在过去的五年中,Merit Medical Systems的每股收益年均增长23%。 这种每股收益的增长与该股票价格的年均增长27%相当接近。 因此,可以得出这样的结论,即对该股票的情绪变化不大。 相反,股票价格几乎与每股收益的增长相对应。
You can see how EPS has changed over time in the image below (click on the chart to see the exact values).
您可以在下面的图片中查看每股收益如何随时间变化(单击图表以查看确切的价值)。
It is of course excellent to see how Merit Medical Systems has grown profits over the years, but the future is more important for shareholders. This free interactive report on Merit Medical Systems' balance sheet strength is a great place to start, if you want to investigate the stock further.
看到美国医疗系统多年来利润增长是很好的,但对股东来说,未来更重要。如果您想进一步研究该股票,Merit Medical Systems的资产负债表强度免费互动报告是一个很好的起点。
A Different Perspective
不同的观点
It's good to see that Merit Medical Systems has rewarded shareholders with a total shareholder return of 46% in the last twelve months. That gain is better than the annual TSR over five years, which is 27%. Therefore it seems like sentiment around the company has been positive lately. Given the share price momentum remains strong, it might be worth taking a closer look at the stock, lest you miss an opportunity. If you would like to research Merit Medical Systems in more detail then you might want to take a look at whether insiders have been buying or selling shares in the company.
很高兴看到美国医疗系统在过去十二个月里回报股东总回报率为46%。这一增长优于过去五年的年度TSR,为27%。因此,最近的公司情绪似乎是积极的。鉴于股价动能仍然强劲,您可以更仔细地观察该股票,以免错过机会。如果您想对美国医疗系统进行更详细的研究,您可能想查看公司内部人员是否一直在购买或出售股票。
If you are like me, then you will not want to miss this free list of undervalued small caps that insiders are buying.
如果您像我一样,就不会希望错过这份免费的内部人士正在购买的低估小市值股票列表。
Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on American exchanges.
请注意,本文所引述的市场回报反映了目前在美国交易所上市的股票的市场加权平均回报。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
对本文有任何反馈?对内容有任何疑虑?请直接与我们联系。或者,发送电子邮件至editorial-team@simplywallst.com。
这篇文章是Simply Wall St的一般性文章。我们根据历史数据和分析师预测提供评论,只使用公正的方法论,我们的文章并不意味着提供任何金融建议。文章不构成买卖任何股票的建议,也不考虑您的目标或您的财务状况。我们的目标是带给您基本数据驱动的长期关注分析。请注意,我们的分析可能不考虑最新的价格敏感公司公告或定性材料。Simply Wall St没有任何股票头寸。